Abiopharma

🔍 Anastasiou Peter (Executive)

Company: Harmony Biosciences Holdings, Inc. (HRMY)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 212,241 shares of Stock Option at $27.74 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2036-04-02 | equity_swap_involved: 0 | shares_owned_after: 212,241.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The stock option vests with respect to 25% of the underlying shares on April 2, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.